Tech Company Financing Transactions

Nuclera Funding Round

Elevage Medical Technologies, British Patient Capital and Cambridge Innovation Capital participated in a $75 million funding round for Nuclera. The financing was announced on 10/16/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

137 Cambridge Science Park Milton Rd.
Cambridge, CB4 0GD
UK

Phone

Undisclosed

Website

www.nuclera.com

Email Address

[email protected]

Overview

Nuclera is a Bioprinter company that enables life science researchers to accelerate breakthrough improvements in human health through easy access of biomolecules.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Chen

        

Chief Financial Officer

Jiahao Huang

        

Chief Technical Officer

Gordon McInroy

        

Vice President

Colin Barnes

        

Vice President

Eugene Bragin

        

VP - Bus. Development

George Easow

        

VP - Human Resources

Charu Maini

        

VP - Marketing

Kristine Friscino

        

VP - R & D

Tobias Ost

        

VP - R & D

Rick Paolini

        

Browse more venture capital transactions:

Prev: 10/16/2024: King Energy venture capital transaction
Next: 10/16/2024: Octavia Carbon venture capital transaction

Share this article

News on VC Transactions

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary